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Adenosine is commonly used as a pharmacological agent in myocardial perfusion imaging,
as an antiarrhythmic agent, and in Cath Lab. during PCI for treating no reflow phenome-
non. Coronary spasm has been reported following adenosine injection during stress im-
aging. We report a rare complication with ST segment elevation, following adenosine
injection, given for treatment of supraventricular tachycardia.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Adenosine is widely used as a pharmacological agent for
stress myocardial perfusion imaging as it is a potent coronary
vasodilator1 as well as treatment of supraventricular tachy-
cardia.2 It is also used for treatment of no reflow phenomenon
during PCI.3 Coronary vasospasm leading to ST elevation
during MPI has been reported rarely4,5 which resolved spon-
taneously on discontinuation of infusion. Isolated case reports
of transient ST elevation following adenosine injection, given
for treatment of SVT are there,6 but to our knowledge no cases
have been reported from the Indian subcontinent.2. Case report
A 39-year-old female presented to emergency with complaint
of sudden onset palpitation, 2 h prior to admission. There wasmail.com, parneesharora
2013, Cardiological Societno history of chest discomfort or syncope accompanying
palpitations. She did not have any history of previous such
episodes. On examination pulse rate was rapid with a sys-
temic blood pressure of 100/80 mmHg. Rest of clinical exam-
ination was unremarkable. ECG was done and it revealed SVT
with heart rate of 200 BPM (Fig. 1A). Vagal maneuvers were
unsuccessful in terminating the tachycardia. Intravenous
adenosine bolus of 6.0 mg was planned and given through
large bore cubital vein. The tachycardia terminated following
adenosine injection, however upon cessation of tachycardia,
patient started developing ST segment elevation noted on
monitor. ECG done revealed ST elevation in inferior leads,
consistent with inferior wall myocardial infarction (Fig. 1B).
Patient developed hypotension and started gasping. She was
immediately intubated. Echocardiography revealed regional
wall motion abnormality in inferior wall. ST segment started
settling after 4e5 min. Patient was started on inotropes
and taken to Cath Lab with intent to perform primary PTCA.@gmail.com (P. Arora).
y of India. All rights reserved.
Fig. 1 e (A): ECG suggestive of SVT and adenosine response. (B): ECG showing ST Elevation in inferior leads. (C): ECG showing
settling of ST segment.
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Fig. 2 e (A): Normal left coronary system. (B): Normal right coronary system.
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nary arteries (Fig. 2A and B) without any evidence of thrombus
with TIMI III flow. Subsequent ECG done showed complete
normalization of ST segment without any Q wave (Fig. 1C).
There was no rise in cardiac enzymes and troponin I did not
show any rise. Blood pressure gradually improved on ino-
tropes and fluid and patient was extubated successfully after
6 h. Inotropes were weaned off and subsequent recovery
was uncomplicated. Predischarge echocardiography did not
reveal any regional wall motion abnormality. She was dis-
charged on the 4th day.3. Discussion
Most of side effects reported with adenosine injection such as
flushing, headache, nausea, chest discomfort, shortness of
breath are benign, mild and transient in nature.2 Coronary
spasm following injection of adenosine is rare but not an
unknown entity.6 Since the patient developed ST elevation
after injection of adenosine which reverted to normal within a
few minutes, cause and effect relationship seems highly
likely. This is further reinforced by the fact that coronaries
were normal without any evidence of thrombus, ruling out
coronary atherosclerotic disease, or dissection as the likely
etiology. Hence coronary spasm looks like the most logical
possibility. Cardiac enzymes were not elevated because of
short duration of spasm.
Adenosine is a potassium channel opener and acts on
adenosine receptors in sinoatrial, atrioventricular node and
ventricular myocytes. It has a negative chronotropic action
and at same time causes coronary vasodilation. Coronary
vasospasm due to adenosine is rare, but has been reported
most often during stress MPI.4,5 Rare case reports following
administration for treatment of SVT have now started
appearing.6
The mechanism resulting in such a phenomenon may be
abrupt withdrawal of short lasting vasodilator effect of
adenosine.7 Coronary hypersensitivity in patients prone to
develop spasm, like patients with prinzmetals angina may be
an added mechanism. However the exact mechanism is still
unclear.8,9 Autonomic nervous system may have a role to
play.10 Sympathetic nervous system activation, secondary tobaroreceptor stimulation caused by hypotensive and vasodi-
lator effect, may cause coronary spasm by triggering cate-
cholamine release. Molecular abnormalities in K ATP channel
may in part explain paradoxical spasm.114. Conclusion
The above case demonstrates a potentially life threatening
and hazardous complication of adenosine. Fortunately it is a
rare phenomenon. However caution should be exercised
especially in patients with previous history suggestive of
vasospastic angina. Sudden onset of chest pain following
adenosine injection, should alert the clinician of this rare
possibility. Most cases resolve spontaneously, but one should
be prepared for occasional adverse outcome.Conflicts of interest
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